Trial Profile
Tau PET Imaging in the NACC Study Cohort: Modulators of MTL Subregion Structure and Function in Normal and Pathological Aging
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 May 2023
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 27 Apr 2023 Planned End Date changed from 31 May 2023 to 31 May 2024.
- 27 Apr 2023 Planned primary completion date changed from 31 May 2023 to 31 May 2024.
- 16 May 2022 Planned End Date changed from 31 May 2022 to 31 May 2023.